These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 29636685)

  • 1. Nanobody-Based Biologics for Modulating Purinergic Signaling in Inflammation and Immunity.
    Menzel S; Schwarz N; Haag F; Koch-Nolte F
    Front Pharmacol; 2018; 9():266. PubMed ID: 29636685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of nanobody-based biologics targeting purinergic checkpoints in tumor models
    Demeules M; Scarpitta A; Hardet R; Gondé H; Abad C; Blandin M; Menzel S; Duan Y; Rissiek B; Magnus T; Mann AM; Koch-Nolte F; Adriouch S
    Front Immunol; 2022; 13():1012534. PubMed ID: 36341324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Methodological Approach Using rAAV Vectors Encoding Nanobody-Based Biologics to Evaluate ARTC2.2 and P2X7
    Gondé H; Demeules M; Hardet R; Scarpitta A; Junge M; Pinto-Espinoza C; Varin R; Koch-Nolte F; Boyer O; Adriouch S
    Front Immunol; 2021; 12():704408. PubMed ID: 34489954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of Antibody and Nanobody Tools for P2X7.
    Stähler T; Danquah W; Demeules M; Gondé H; Hardet R; Haag F; Adriouch S; Koch-Nolte F; Menzel S
    Methods Mol Biol; 2022; 2510():99-127. PubMed ID: 35776322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanobodies as probes to investigate purinergic signaling.
    Eggers M; Rühl F; Haag F; Koch-Nolte F
    Biochem Pharmacol; 2021 May; 187():114394. PubMed ID: 33388283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Progress on role of extracellular ATP and its metabolite adenosine in immunoregulation: Review].
    Wang C; Yin Q; Su Z; Xia L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Dec; 36(12):1134-1140. PubMed ID: 33325366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daratumumab and Nanobody-Based Heavy Chain Antibodies Inhibit the ADPR Cyclase but not the NAD
    Baum N; Fliegert R; Bauche A; Hambach J; Menzel S; Haag F; Bannas P; Koch-Nolte F
    Cancers (Basel); 2020 Dec; 13(1):. PubMed ID: 33396591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ectonucleotidases as regulators of purinergic signaling in thrombosis, inflammation, and immunity.
    Deaglio S; Robson SC
    Adv Pharmacol; 2011; 61():301-32. PubMed ID: 21586363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Divergent regulatory roles of extracellular ATP in the degranulation response of mouse bone marrow-derived mast cells.
    Yoshida K; Ito M; Matsuoka I
    Int Immunopharmacol; 2017 Feb; 43():99-107. PubMed ID: 27988461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purine Release, Metabolism, and Signaling in the Inflammatory Response.
    Linden J; Koch-Nolte F; Dahl G
    Annu Rev Immunol; 2019 Apr; 37():325-347. PubMed ID: 30676821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD38-Specific Biparatopic Heavy Chain Antibodies Display Potent Complement-Dependent Cytotoxicity Against Multiple Myeloma Cells.
    Schütze K; Petry K; Hambach J; Schuster N; Fumey W; Schriewer L; Röckendorf J; Menzel S; Albrecht B; Haag F; Stortelers C; Bannas P; Koch-Nolte F
    Front Immunol; 2018; 9():2553. PubMed ID: 30524421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD73 on T Cells Orchestrates Cardiac Wound Healing After Myocardial Infarction by Purinergic Metabolic Reprogramming.
    Borg N; Alter C; Görldt N; Jacoby C; Ding Z; Steckel B; Quast C; Bönner F; Friebe D; Temme S; Flögel U; Schrader J
    Circulation; 2017 Jul; 136(3):297-313. PubMed ID: 28432149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifaceted Effects of Extracellular Adenosine Triphosphate and Adenosine in the Tumor-Host Interaction and Therapeutic Perspectives.
    de Andrade Mello P; Coutinho-Silva R; Savio LEB
    Front Immunol; 2017; 8():1526. PubMed ID: 29184552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanobodies that block gating of the P2X7 ion channel ameliorate inflammation.
    Danquah W; Meyer-Schwesinger C; Rissiek B; Pinto C; Serracant-Prat A; Amadi M; Iacenda D; Knop JH; Hammel A; Bergmann P; Schwarz N; Assunção J; Rotthier W; Haag F; Tolosa E; Bannas P; Boué-Grabot E; Magnus T; Laeremans T; Stortelers C; Koch-Nolte F
    Sci Transl Med; 2016 Nov; 8(366):366ra162. PubMed ID: 27881823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purinergic signaling during intestinal inflammation.
    Longhi MS; Moss A; Jiang ZG; Robson SC
    J Mol Med (Berl); 2017 Sep; 95(9):915-925. PubMed ID: 28547076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel biologics targeting the P2X7 ion channel.
    Koch-Nolte F; Eichhoff A; Pinto-Espinoza C; Schwarz N; Schäfer T; Menzel S; Haag F; Demeules M; Gondé H; Adriouch S
    Curr Opin Pharmacol; 2019 Aug; 47():110-118. PubMed ID: 30986625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotinamide adenine dinucleotide (NAD) and its metabolites inhibit T lymphocyte proliferation: role of cell surface NAD glycohydrolase and pyrophosphatase activities.
    Bortell R; Moss J; McKenna RC; Rigby MR; Niedzwiecki D; Stevens LA; Patton WA; Mordes JP; Greiner DL; Rossini AA
    J Immunol; 2001 Aug; 167(4):2049-59. PubMed ID: 11489987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the expression and function of the P2X7 receptor and ART1 in human regulatory T-cell subsets.
    Cortés-Garcia JD; López-López C; Cortez-Espinosa N; García-Hernández MH; Guzmán-Flores JM; Layseca-Espinosa E; Portales-Cervantes L; Portales-Pérez DP
    Immunobiology; 2016 Jan; 221(1):84-93. PubMed ID: 26307000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant circulating levels of purinergic signaling markers are associated with several key aspects of peripheral atherosclerosis and thrombosis.
    Jalkanen J; Yegutkin GG; Hollmén M; Aalto K; Kiviniemi T; Salomaa V; Jalkanen S; Hakovirta H
    Circ Res; 2015 Mar; 116(7):1206-15. PubMed ID: 25645301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenine nucleotides as paracrine mediators and intracellular second messengers in immunity and inflammation.
    Fliegert R; Heeren J; Koch-Nolte F; Nikolaev VO; Lohr C; Meier C; Guse AH
    Biochem Soc Trans; 2019 Feb; 47(1):329-337. PubMed ID: 30674608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.